C79.6
Secondary malignant neoplasm of ovary
Clinical Classification Guidelines
Medical Intelligence & Overview
Secondary malignant neoplasm of the ovary refers to cancer that has spread to the ovaries from another part of the body. Unlike primary ovarian cancer, which originates in the ovaries, this condition occurs when cancer cells from a different primary site travel via the bloodstream or lymphatic system to establish a new tumor in the ovaries. Recognizing and understanding this condition is vital for proper diagnosis and management, as it reflects advanced systemic disease.
Causes & Symptoms
Clinical Causes: Cancer originating from other organs such as the breast, colon, stomach, or pancreas that metastasizes to the ovaries. Spread of malignant cells through blood or lymphatic routes after primary tumor development. Partial or complete serous carcinomas of other sites that invade ovarian tissue, leading to secondary involvement.
Key Symptoms: Pelvic or abdominal pain or discomfort. Unexplained weight loss or loss of appetite. Abdominal bloating, swelling, or ascites (accumulation of fluid). Changes in bowel or bladder habits, such as constipation or increased frequency. Feeling of fullness after eating small amounts of food. General fatigue or weakness.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation, imaging studies, and laboratory tests. Doctors may use ultrasound, CT scans, or MRI to identify ovarian masses and assess disease spread. Blood tests, including tumor markers, can assist in characterization. Definitive diagnosis usually depends on pathological examination of tissue obtained through biopsy or surgery, which confirms the presence of metastatic cancer cells originating from another site.
Treatment Protocols: Treatment strategies focus on controlling the spread of disease and improving quality of life. These may include systemic therapies such as chemotherapy, targeted therapy, or hormonal therapy depending on the primary cancer source. Surgical intervention might be considered for symptom relief or diagnostic purposes but is typically less extensive than primary ovarian cancer surgeries. Palliative care and supportive treatments are essential components for managing symptoms and maintaining well-being.
Clinical Advice & FAQs
Billing Guidance
Is C79.6 a billable ICD-10 code?
Yes, C79.6 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C79.6?
Clinical documentation must specify the nature of Secondary malignant neoplasm of ovary and any associated comorbidities for accurate reporting.
Cite this Clinical Reference